Clinical Trial Update: Avastin/FOLFIRI in Combination With Curcumin in Colorectal Cancer Patients With Unresectable Metastasis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Avastin/FOLFIRI with curcumin in colorectal cancer with unresectable metastases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Curcumin (curcumin)
• FOLFIRI (irinotecan, leucovorin, 5-fluorouracil)

Snippet

Sponsor: Gachon University Gil Medical Center | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED